Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More
Discover how the Agilent BioTek Cytation cell imaging multimode reader and ViQi’s AVIA provide a powerful, integrated solution for viral infectivity analysis. Download the application note to explore how this innovative approach offers key advantages over traditional assays, including: High-throughput, cost-effective analysis: AVIA minimizes reagent use, incubation time, and replicate needs,… Read More
DDW’s Megan Thomas speaks with ICON's IT Director, Marco Heldoorn, about leveraging artificial intelligence (AI) to enhance efficiency, decision-making, and patient outcomes across the drug development lifecycle, from early feasibility to post-marketing. MT: Could you provide an overview of your findings when it comes to drug development and AI? TO:… Read More
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich has announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyse an ambitious future phase to… Read More
Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More
DDW’s Megan Thomas speaks with Dr Jennifer Bradford, VP, Head of Data Science at Coronado Research, about the impact of artificial intelligence (AI) on the clinical development process, how to overcome common barriers to adoption and the developments with the potential to accelerate innovation. MT: How do you envision AI… Read More
Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More
Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More
Hosted by Drug Discovery World and sponsored by Benchling, this free webinar explores the impact of AI on drug discovery innovation. The webinar sees AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development. You will hear from Martin… Read More
Biotechnology company Insilico Medicine has unveiled a new study showcasing how the company’s advanced generative AI platform and integrated workflow helped to identify and validate ENPP1 as a critical immune checkpoint among multiple solid tumours, which helped to the development of a highly specific oral ENPP1 inhibitor, ISM5939. Read More
Adityo Prakash, CEO of Verseon, introduces a new mathematical approach to computing molecular interactions. The objective of small-molecule drug discovery is to find binders to target proteins involved in disease processes. However, the discovery and development of novel small-molecule therapeutics remains one of the most resource-intensive endeavors in biomedical science. Read More
Various imaging modalities are used throughout the process of drug discovery and development, both in the preclinical and clinical phases. According to analysts, Valuates, the global preclinical imaging market was valued at $1887.9 million in 2023 and is anticipated to reach $3021.2 million by 2030. Read More
This eBook, sponsored by Aurora Microplates, examines the role of imaging and its significance to the success of drug discovery and development. Download this exclusive eBook to learn more about: Two technological developments that have revolutionised the role of imaging in drug discovery The latest innovations in flow cytometry technology… Read More
Moderna and Benchling have extended their collaboration into a broader rollout across the company’s research organisation. The expansion will bring hundreds of Moderna’s scientists onto a unified, AI-ready research and development digital platform designed to accelerate discovery and innovation. “Moderna was built on the belief that technology and science together… Read More
The US Food and Drug Administration (FDA) has announced an aggressive timeline to scale use of artificial intelligence (AI) internally across all FDA centres by 30 June 2025, following the completion of a new generative AI pilot for scientific reviewers. “I was blown away by the success of our first… Read More
DDW Editor Reece Armstrong speaks to Adityo Prakash, CEO of Verseon, about AI and deep learning in drug discovery and how neural networks within AI are influencing drug discovery approaches. RA: Could you explain the architectural differences between Verseon’s VersAI’s neural network and deep learning neural networks? AP: The underlying… Read More
